Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

BACKGROUND: Wnt signaling is a cellular pathway involved in embryogenesis, development, and neoplasia. Wnt-pathway activation may accelerate prostate cancer androgen-independent growth and mediate antiandrogen resistance. Since 10–20% of advanced prostate cancers harbor Wnt-activating mutations, we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Urol
Main Authors: Velho, Pedro Isaacsson, Fu, Wei, Wang, Hao, Mirkheshti, Nooshin, Qazi, Fahad, Lima, Fabiola A.S., Shaukat, Farah, Carducci, Michael A., Denmeade, Samuel R., Paller, Channing J., Markowski, Mark C., Marshall, Catherine H., Eisenberger, Mario A., Antonarakis, Emmanuel S.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893106/
https://ncbi.nlm.nih.gov/pubmed/31176623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.05.032
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares